Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Jensen

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
The Journal of Infection|February 4, 2025
Measles-mumps-rubella vaccination at 6 months of age and the risk of atopic disease in the first year of life: Results from a Danish placebo-controlled randomised trialAnne Cathrine Zimakoff, Andreas Jensen, Michelle Malon, et al.
The Science of the Total Environment|March 11, 2025
Time-efficient approach for environmental transformation and bioavailability assessment of isotopically enriched nanoparticles to increase environmental relevanceSebastian Kuehr, Ralf Kaegi, Johannes Raths, et al.
Vaccine|February 6, 2025
Genetic associations with measles PRNT and IgG antibody response to MMR vaccination in 6- and 15-month-old childrenJesper Kiehn Sørensen, Andreas Jensen, Anne Cathrine Zimakoff, et al.
Eclinicalmedicine|January 31, 2024
Immunogenicity and reactogenicity following MMR vaccination in 5-7-month-old infants: a double-blind placebo-controlled randomized clinical trial in 6540 Danish infantsDorthe Maria Vittrup, Andreas Jensen, Jesper Kiehn Sørensen, et al.
Plos One|January 27, 2026
Defining the population of adolescents in need of comprehensive transitional care based on diagnosis, visit frequency, and disease complexityMaj Beldring Henningsen, Kirsten Arntz Boisen, Pi Vejsig Madsen, et al.
Lancet (London, England)|May 3, 2026
Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trialMette Kruse Klausen, Signe Keller Justesen, Julie Niemann Pedersen, et al.
JAMA Psychiatry|December 3, 2025
Semaglutide and Early-Stage Metabolic Abnormalities in Individuals With Schizophrenia Spectrum Disorders: A Randomized Clinical TrialMarie R Sass, Mette Kruse Klausen, Christine R Schwarz, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
The Journal of Infection|February 4, 2025
Measles-mumps-rubella vaccination at 6 months of age and the risk of atopic disease in the first year of life: Results from a Danish placebo-controlled randomised trialAnne Cathrine Zimakoff, Andreas Jensen, Michelle Malon, et al.
The Science of the Total Environment|March 11, 2025
Time-efficient approach for environmental transformation and bioavailability assessment of isotopically enriched nanoparticles to increase environmental relevanceSebastian Kuehr, Ralf Kaegi, Johannes Raths, et al.
Vaccine|February 6, 2025
Genetic associations with measles PRNT and IgG antibody response to MMR vaccination in 6- and 15-month-old childrenJesper Kiehn Sørensen, Andreas Jensen, Anne Cathrine Zimakoff, et al.
Eclinicalmedicine|January 31, 2024
Immunogenicity and reactogenicity following MMR vaccination in 5-7-month-old infants: a double-blind placebo-controlled randomized clinical trial in 6540 Danish infantsDorthe Maria Vittrup, Andreas Jensen, Jesper Kiehn Sørensen, et al.
Plos One|January 27, 2026
Defining the population of adolescents in need of comprehensive transitional care based on diagnosis, visit frequency, and disease complexityMaj Beldring Henningsen, Kirsten Arntz Boisen, Pi Vejsig Madsen, et al.
Lancet (London, England)|May 3, 2026
Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trialMette Kruse Klausen, Signe Keller Justesen, Julie Niemann Pedersen, et al.
JAMA Psychiatry|December 3, 2025
Semaglutide and Early-Stage Metabolic Abnormalities in Individuals With Schizophrenia Spectrum Disorders: A Randomized Clinical TrialMarie R Sass, Mette Kruse Klausen, Christine R Schwarz, et al.
Pageof 4